Lamivudine
C8H11N3O3S
229.26
C8H11N3O3S·0.2 CH3OH 235.66
C8H11N3O3S·0.2 H2O 232.86
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-;
(–)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine [134678-17-4]
C8H11N3O3S·0.2 CH3OH 235.66
C8H11N3O3S·0.2 H2O 232.86
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-;
(–)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine [134678-17-4]
DEFINITION
Lamivudine contains NLT 98.0% and NMT 102.0% of lamivudine (C8H11N3O3S), calculated on the anhydrous and solvent-free basis. If labeled as a methanol solvate, it contains NLT 98.0% and NMT 102.0% of lamivudine (C8H11N3O3S), calculated on the anhydrous, methanol-free, and solvent-free basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Lamivudine RSUSP Lamivudine Resolution Mixture B RS
USP Lamivudine Resolution Mixture A RS
USP Salicylic Acid RS